title: Pain in adolescent girls receiving human papillomavirus vaccine with concomitantly administered vaccines.
abstract: Using the Faces Pain Scale - Revised, we assessed injection site pain 10 minutes after vaccination in young females randomized to receive either quadrivalent human papillomavirus vaccine (HPV4) before or after concomitantly administered vaccines. Although pain was modestly more after HPV4 injection than after other vaccines, the pain intensity after HPV4 injection was significantly less in those who received HPV4 before receiving other concomitant vaccines.
authors.affiliation: From the *Clinical Vaccine Unit and Primary Care Research Consortium, Duke University School of Medicine, Durham, NC and †Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Emmanuel B
authors.initials: EB
authors.lastname: Walter
authors.forename: Alex R
authors.initials: AR
authors.lastname: Kemper
authors.forename: Rowena J
authors.initials: RJ
authors.lastname: Dolor
authors.forename: Eileen F
authors.initials: EF
authors.lastname: Dunne
mesh_terms: D000293:Adolescent; D002648:Child; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D010146:Pain / Q000139:chemically induced*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines